Full-Time

Operations Tech I

LFB

LFB

1,001-5,000 employees

Public health biopharmaceuticals via plasma-derived products

Compensation Overview

$23 - $24.50/hr

Webster, MA, USA

In Person

Category
Biology & Biotech (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • High School Diploma or GED required
  • 4-7 years laboratory animal experience AS or BS (in related discipline) with at least 3 years laboratory animal experience
  • AALAS certification at the Laboratory Animal Technician (LAT) level required
  • Must be able to work in a team-oriented production environment with attentiveness to detail, accuracy and strong organizational skills
  • Strong attention to detail and compliance with Good Documentation Practices
  • Strong verbal and written communication skills with ability to read, understand, and follow written and verbal instructions
  • Demonstrated commitment to teamwork with strong interpersonal and leadership skills with team members
  • Strong working knowledge of computer applications (Microsoft Word, Excel, Outlook, PowerPoint and internet)
  • Ability to record and evaluate data
  • Ability to push/pull wheeled carts weighing up to 500 pounds
  • Ability to lift and manipulate up to 50 pounds
  • Duties require long periods of standing and/or sitting for an average of six hours a day
  • May be exposed to materials and chemicals that are potentially allergenic
  • Duties involve repetitive motion of hands and wrists
Responsibilities
  • Daily animal care activities including feeding, observations/identification of clinical concerns, and nail trimming
  • Husbandry activities including cage changes/cleaning, use of power wash and chemical dispensing equipment, and general facility sanitization and support
  • Milking of rabbits and potential advanced operational support to meet production goals and adhere to schedules
  • Proper restraint of rabbits for general care, transfers, sample collection, and advanced handling (Artificial Insemination restraint)
  • Technical skills including intraperitoneal, intramuscular, intravenous, subcutaneous, and intracardiac injections, and intravenous blood collection procedures
  • Assess animals and initiate veterinary care and animal treatments
  • Perform animal identification applications including ear tags, tattoos and RFID transponders; generate and track colony identification information and program RFID transponders
  • Provide advanced support and training of new staff in all husbandry and/or milking procedures
  • Evaluate processes and propose improvements to Management
  • Maintain oversight of complex processes such as breeding strategies and preventive maintenance of milk equipment, and provide instructions to peers to complete associated tasks
  • Utilize computer and paper-based systems to document and record information to assure regulatory and company policy compliance
  • Have a firm understanding of applicable Quality Systems (e.g., change control, deviations)
  • Write, modify, and provide training on Standard Operating Procedures and Work Instructions; serve as a designated trainer on assigned tasks
  • Demonstrate ability to work on assigned projects independently with little or no supervision
  • Identify safety issues and initiate corrective actions; communicate animal welfare concerns
  • Exhibit understanding of applicable animal care and use guidelines
  • Weekend and holiday coverage required on a rotating basis

LFB is a French biopharmaceutical company that develops and manufactures medicines from plasma and biotech products. It collects plasma, fractionates it into medicines, and also produces recombinant proteins for rare diseases in immunology and hemostasis, sold in many countries. It stands out because it started as a state-initiated public health mission and remains state-owned with the French State as sole shareholder, plus vertical integration through acquisitions of plasma collection firms. Its goal is to ensure a reliable supply of essential medicines for public health while growing as a global biopharma player.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Courcebœufs, France

Founded

1994

Your Connections

People at LFB who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ESCAPE strategy doubles bioproduction capacity by 2025.
  • Amber Plasma acquisition boosts Czech centers to 24.
  • Arras site triples medication production for patient demand.

What critics are saying

  • FDA bans cripple LFB USA rPRO™ proteins in 12-18 months.
  • CSL Behring squeezes Europlasma's 24 centers in 6-12 months.
  • Grifols captures 25% hemostasis share in 12-24 months.

What makes LFB unique

  • LFB specializes in plasma-derived medicines from 1994 French state initiative.
  • rPRO™ technology expresses recombinant proteins in transgenic animal milk.
  • Europlasma secures plasma via 24 Central European collection centers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Remote Work Options

Unlimited Paid Time Off

Flexible Work Hours

Paid Vacation

Hybrid Work Options

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

Conference Attendance Budget

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Education allowance

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
MyPharma Editions
May 30th, 2024
LFB Acquires Amber Plasma in Czech Republic

Title: "LFB Acquires Amber Plasma in the Czech Republic" LFB and its subsidiary Europlasma have acquired Amber Plasma, which operates 12 plasma collection centers in the Czech Republic. This acquisition increases Europlasma's total to 24 centers in Central Europe, enhancing LFB's plasma collection capacity. The move supports LFB's goal to meet growing patient demand and will aid in the launch of a new production site in Arras, France, tripling its medication production capacity.